Product Description
Overall, the global robotic-assisted neurosurgery system market was valued at $104.7 million in 2021. This is expected to increase over the forecast period at a CAGR of 12.8% to reach $243 million.
The full report suite on the global market for robotic-assisted neurosurgery systems includes two segments: capital equipment and services and maintenance revenue. Regional volumes of robotic-assisted neurosurgery procedures are also reported.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2028, and Historical Data to 2018
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
PROCEDURE NUMBERS
In 2021, the global robotic-assisted neurosurgery market experienced a strong increase in the number of procedures performed. In 2020, the market saw a notable decrease in procedure volume as a result of the COVID-19 pandemic. In 2021, the procedure numbers fully recovered and surpassed pre-pandemic numbers.
GLOBAL ROBOTIC-ASSISTED NEUROSURGERY SYSTEM MARKET TRENDS
A general trend that is being observed across all segments of the surgical robotics market is increasing use of robots during surgery, especially for surgical robots that possess the capability of performing minimally invasive surgery.
GLOBAL ROBOTIC-ASSISTED NEUROSURGERY SYSTEM MARKET SHARE INSIGHTS
Overall, within the global robotic-assisted neurosurgery system market there are three dominant competitors: Zimmer Biomet, Synaptive Medical, and Medtronic.
Zimmer Biomet led the robotic-assisted neurosurgery market globally in 2021. Zimmer Biomet offers a range of surgical robots that are a part of the ROSA® robotics portfolio. For neurosurgery, the company markets its ROSA® ONE Brain system.
GLOBAL ROBOTIC-ASSISTED NEUROSURGERY SYSTEM MARKET SEGMENTATION SUMMARY
- Capital Equipment
- Services Revenue
- Maintenance Revenue
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2021 |
| Forecast Period | 2022-2028 |
| Historical Data | 2018-2021 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE iDATA?
-
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
